Midori Higashi, DPM
Foot & Ankle Surgery · Seattle, WANPI 1215322532
Payments from drug & device makers
Across 17 payments — averaging $132.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Summit Surgical Corp.$1K
- Paragon 28, Inc.$337
- Heron Therapeutics, Inc.$145
- Orthofix Medical, Inc.$138
- Smith+Nephew$123
- Paratek Pharmaceuticals, Inc.$39
- plus $91 from 5 others
What the payments were for
- Travel & lodging$1095%
- Food & beverage$76434%
- Education$1,38261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Summit Surgical Corp. | 2 | $1,382 |
| Paragon 28, Inc. | 4 | $337 |
| Heron Therapeutics, Inc. | 2 | $145 |
| Orthofix Medical, Inc. | 1 | $138 |
| Smith+Nephew | 1 | $123 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Stryker | 1 | $38 |
| Eagle Pharmaceuticals, Inc. | 1 | $15 |
| Treace Medical Concepts, Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $13 |
| Medela LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Physio-Stim$138
- PARATROOPER$128
- Zynrelef$125
- Stravix$123
- Grafix$123
- STRAVIX PL$123
- GRAFIX PL$123
- Product Portfolio$109
How this compares
$2,255 in reported general payments places this provider in the 55th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 30 | $788 |
| Ondansetron OdtOndansetron | 20 | $277 |
| Cephalexin | 36 | $244 |
| Oxycodone Hcl | 31 | $213 |
| Doxycycline Hyclate | 16 | $182 |
| Hydroxyzine Pamoate | 13 | $96 |
| Meloxicam | 13 | $18 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Seattle
- David DalstromSeattle$497K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Kivanc AtesokSeattle$16K
- Adam SangeorzanSeattle$12K
- Christopher PriceSeattle$11K
- Kenneth ChinSeattle$10K
- Gregory GrantSeattle$6K
- Anthony LoSeattle$6K
- Maduwilla SilvaSeattle$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.